Related Experiment Videos
Thyroid cancer: different outcomes to chemotherapy according to tumour histology
European Journal of Cancer (Oxford, England : 1990)
|December 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
Annals of oncology : official journal of the European Society for Medical Oncology·2025
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.
European journal of cancer (Oxford, England : 1990)·2026
Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.
European journal of cancer (Oxford, England : 1990)·2026
Genomic landscape of sweat gland carcinomas: Clinical applications and future directions.
European journal of cancer (Oxford, England : 1990)·2026
Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.
European journal of cancer (Oxford, England : 1990)·2026
Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.
European journal of cancer (Oxford, England : 1990)·2026
Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial).
European journal of cancer (Oxford, England : 1990)·2026